GPR75 and metabolic dysfunction-associated steatotic liver disease: Under HFD conditions, Gpr75 knockout mice exhibited lower food intake, increased physical activity, lower liver weight, and decreased hepatic triglyceride and lipid levels, suggesting that Gpr75 deletion protects against non-alcoholic fatty liver disease (NAFLD).